To avoid Medicaid penalties, Glaxo and other drugmakers lowered prices. For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.
A push in 2025 to eliminate the Affordable Care Act could flop for the same reason that 2017's effort on that front failed: a slim Senate majority for.